ArticleBMC pulmonary medicine2026
Plethysmographic measurements as novel predictors of mortality in pulmonary embolism.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06508112 (Pleth Variability Index), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pleth Variability Index: A Potential New Marker for Predicting the Mortality of Pulmonary Embolism?
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary embolism(PE) is a ventilation/perfusion(V/Q) disorder due to obstruction of the pulmonary artery, typically by a thrombus. The Pleth Variability Index(PVI) is a noninvasive measure reflecting dynamic changes in the perfusion index(PI), observed through photoplethysmography over at least one respiratory cycle. This study aims to investigate the prognostic value of plethysmographic parameters in patients with PE, hypothesizing that these parameters may serve as a reliable guide in a condition where impaired perfusion plays a critical role.
methodsData were collected from patients over 18 years old, diagnosed with PE in the emergency department, including demographic information, risk scores, and measurements. PVI and PI values were analyzed across mortality groups. A survival analysis was performed to assess the impact of PVI and PI on 1-year mortality. The study followed the STROBE checklist for evaluation.
results49-patients were included in this prospective, single-center study. The PVI was significantly higher, and PI was significantly lower in the deceased group compared to the survivors(p = 0.027, p = 0.011). AUC values for PVI, PESI score, and PI were 0.714, 0.820, and 0.745, respectively. The negative predictive value of PESI was 100%, while PVI showed the highest positive predictive value(53.5%). The mean survival time was significantly shorter for patients with PVI > 40 and PI < 1.9(p = 0.001, p = 0.002). An increase in PVI was associated with a ~ 5-fold higher risk of death(HR:5.04, 95% CI:1.50-16.92, p = 0.009).
conclusionsPVI is a noninvasive, rapid, and objective tool for predicting mortality in PE patients in the emergency department. This study is the first to evaluate PVI in PE.
trial registrationClinicalTrials.gov Identifier: NCT06508112. Registered on 12 July 2024.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.